(Q26829487)

English

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group (English)

1 reference

restless legs syndrome

0 references

1 reference

based on heuristic

inferred from title

6

0 references

Jacques Montplaisir

8

0 references

Richard P Allen

10

object named as

Richard P. Allen

1 reference

Christopher J Earley

5

object named as

Christopher J. Earley

1 reference

Diego García-Borreguero

1

object named as

Diego Garcia-Borreguero

1 reference

7

object named as

Mauro Manconi

1 reference

2

object named as

Ralf Kohnen

1 reference

author name string

Michael H. Silber

3

1 reference

John W. Winkelman

4

1 reference

Yuichi Inoue

9

1 reference

language of work or name

1 reference

publication date

July 2013

1 reference

1 reference

14

1 reference

7

1 reference

675-84

1 reference

Treatment of restless legs syndrome with levodopa plus benserazide

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment of restless legs syndrome with dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Ropinirole and restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

One‐year treatment with standard and sustained‐release levodopa: Appropriate long‐term treatment of restless legs syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Piribedil for restless legs syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up on restless legs syndrome patients treated with opioids

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Methadone for refractory restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life score is primarily affected by the mental rather than the physical component in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

[Quality of life in restless legs syndrome. Influence of daytime sleepiness and fatigue]

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term open-label study of pramipexole in patients with primary restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Restless legs syndrome augmentation associated with tramadol

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing health-related quality of life in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of tetrabenazine use on restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Restless legs syndrome: Understanding its consequences and the need for better treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of response during long-term treatment of restless legs syndrome: Guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term use of pramipexole in the management of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Pergolide associated cardiac valvulopathy based on Ontario administrative data.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramipexole in the treatment of restless legs syndrome: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine agonists and the risk of cardiac-valve regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of restless legs syndrome with gabapentin (Neurontin)

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramipexole in the management of restless legs syndrome: an extended study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of restless legs syndrome with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A 52-week study of gabapentin enacarbil in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004*

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with pramipexole in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Pregabalin in restless legs syndrome with and without neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Levetiracetam can be effective in the treatment of restless legs syndrome with periodic limb movements in sleep: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of medically refractory restless legs syndrome with intrathecal morphine: case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrathecal morphine as a treatment for refractory restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Valvular heart disease in patients taking pergolide

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

An algorithm for the management of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.SLEEP.2013.05.016

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26829487&oldid=2199353313"